Display options
Share it on

Dose Response. 2019 Dec 23;17(4):1559325819893195. doi: 10.1177/1559325819893195. eCollection 2019.

A Nontarget Mechanism to Explain Carcinogenesis Following α-Irradiation.

Dose-response : a publication of International Hormesis Society

Nicholas D Priest

Affiliations

  1. Canadian Nuclear Laboratories, Chalk River, Ontario, Canada.

PMID: 31903068 PMCID: PMC6928537 DOI: 10.1177/1559325819893195

Abstract

This commentary highlights the published data on the metabolic processes that lead to the development of cancer following intakes of asbestos and chemical agents. Following exposure to both, the key initiating event is cell injury leading to cell death that may further lead to inflammation, fibrosis, and cancer. Since α-particle transits also kill cells, it is suggested that cell death and inflammation will also trigger carcinogenesis within tissues irradiated by these particles. Such an explanation would be consistent with the inflammation and fibrosis seen in tumor-bearing tissues irradiated by radon-222, radium-226, thorium-232, plutonium-239, and other α-emitting radionuclides. It would also provide an explanation for dose-related changes in latency and in the similar dose-responses for the same tissue in differently sized species.

© The Author(s) 2019.

Keywords: carcinogenesis; cell injury and death; fibrosis; inflammation; α-radiation

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Int J Radiat Biol. 1994 Jan;65(1):7-17 - PubMed
  2. Health Phys. 1995 Sep;69(3):330-7 - PubMed
  3. Health Phys. 2010 Jan;98(1):42-52 - PubMed
  4. Radiat Environ Biophys. 2009 Aug;48(3):287-94 - PubMed
  5. Radiat Res. 2012 Nov;178(5):447-67 - PubMed
  6. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12611-6 - PubMed
  7. Radiologe. 1999 Aug;39(8):643-51 - PubMed
  8. Health Phys. 1983;44 Suppl 1:299-306 - PubMed
  9. Int J Cancer. 2008 Aug 15;123(4):905-11 - PubMed
  10. Ann N Y Acad Sci. 2000;917:121-34 - PubMed
  11. EMBO Mol Med. 2009 Sep;1(6-7):303-14 - PubMed
  12. Radiat Res. 2008 Dec;170(6):736-57 - PubMed
  13. J Exp Med. 2001 Mar 19;193(6):727-40 - PubMed
  14. J Radiat Res. 2013 Nov 1;54(6):1161-3 - PubMed
  15. World J Gastroenterol. 2016 Mar 28;22(12):3305-14 - PubMed
  16. Health Phys. 1988 Aug;55(2):455-62 - PubMed
  17. Mech Ageing Dev. 2014 Jul;139:31-40 - PubMed
  18. Environ Health Perspect. 1984 Apr;55:129-37 - PubMed
  19. Cancer Res. 2013 Mar 15;73(6):1721-32 - PubMed
  20. J Environ Pathol Toxicol. 1977 Nov-Dec;1(2):279-86 - PubMed
  21. Int J Radiat Biol. 1991 Jan;59(1):229-38 - PubMed
  22. J Cancer Res Clin Oncol. 2015 Nov;141(11):1985-94 - PubMed
  23. Br J Cancer. 1975 Oct;32(4):411-26 - PubMed
  24. Lancet Oncol. 2009 May;10(5):501-7 - PubMed
  25. Int J Radiat Biol. 2015;91(10):810-9 - PubMed
  26. BMC Cancer. 2014 May 10;14:331 - PubMed
  27. Health Phys. 1983;44 Suppl 1:135-48 - PubMed
  28. Nature. 2004 Sep 23;431(7007):461-6 - PubMed
  29. Exp Mol Med. 2017 Jul 21;49(7):e359 - PubMed
  30. J Clin Invest. 2008 Jul;118(7):2516-25 - PubMed
  31. Curr Mol Med. 2010 Jun;10(4):369-73 - PubMed
  32. Radiat Res. 2013 Jul;180(1):100-9 - PubMed

Publication Types